来源:视频滚动新闻
默沙东盘前涨5.79%,现报143.00美元,Moderna盘前一度涨超50%。消息面上,默沙东与Moderna联合开发的个体化新抗原疗法Intismeran Autogene联用Keytruda在III期黑色素瘤试验中达到主要终点,并将就上市申请与监管机构沟通。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.